NASDAQ:CLXT - Calyxt Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Calyxt Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.90 -0.43 (-12.91 %) (As of 04/1/2020 04:00 PM ET) Add Compare Today's Range$2.90Now: $2.90▼$3.2850-Day Range$2.48MA: $4.78▼$6.7252-Week Range$2.40Now: $2.90▼$17.90Volume135,822 shsAverage Volume136,878 shsMarket Capitalization$95.67 millionP/E RatioN/ADividend YieldN/ABeta2.02 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorConsumer Staples Current SymbolNASDAQ:CLXT Previous Symbol CUSIPN/A CIK1705843 Webhttp://www.calyxt.com/ Phone651-683-2807Debt Debt-to-Equity Ratio0.29 Current Ratio8.83 Quick Ratio8.47Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$7.30 million Price / Sales13.11 Cash FlowN/A Price / Cash FlowN/A Book Value$1.90 per share Price / Book1.53Profitability EPS (Most Recent Fiscal Year)($1.21) Net Income$-39,610,000.00 Net Margins-543.00% Return on Equity-52.37% Return on Assets-39.74%Miscellaneous Employees50 Outstanding Shares32,991,000Market Cap$95.67 million Next Earnings Date5/5/2020 (Estimated) OptionableNot Optionable Receive CLXT News and Ratings via Email Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:CLXT Rates by TradingView Calyxt (NASDAQ:CLXT) Frequently Asked Questions How has Calyxt's stock been impacted by COVID-19 (Coronavirus)? Calyxt's stock was trading at $3.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLXT shares have decreased by 13.2% and is now trading at $2.90. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Calyxt? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Calyxt. When is Calyxt's next earnings date? Calyxt is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Calyxt. How were Calyxt's earnings last quarter? Calyxt Inc (NASDAQ:CLXT) released its earnings results on Thursday, March, 5th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.33) by $0.04. The firm had revenue of $3.76 million for the quarter. Calyxt had a negative net margin of 543.00% and a negative return on equity of 52.37%. View Calyxt's earnings history. What guidance has Calyxt issued on next quarter's earnings? Calyxt updated its FY 2020 Pre-Market earnings guidance on Thursday, March, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $13.862-15.322 million, compared to the consensus revenue estimate of $20.48 million. What price target have analysts set for CLXT? 5 Wall Street analysts have issued 1 year target prices for Calyxt's shares. Their forecasts range from $6.00 to $16.00. On average, they expect Calyxt's stock price to reach $11.00 in the next twelve months. This suggests a possible upside of 279.3% from the stock's current price. View analysts' price targets for Calyxt. What are Wall Street analysts saying about Calyxt stock? Here are some recent quotes from research analysts about Calyxt stock: 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (3/12/2020) 2. National Securities analysts commented, " Second Quarter Shows Progress And Growing Pains. With low and lumpy volumes in its first year of commercialization and weather issues reducing planted acreage from prior estimates, CLXT’s second quarter brought a degree of near term revenue uncertainty. OpEx also moved up sequentially more than we estimated. While a modest disappointment, we consider the improvement in distribution network and the market acceptance of the lead product to be encouraging and far more important to the value proposition. Customer Adoption Accelerates. With 20 customers currently, up from low single digits since the first quarter, we believe the market for both oil and meal is strong. As the company builds scale, we do not believe securing customers will be a meaningful hurdle. The next major bar is securing from consumer goods customers, which we expect over the next twelve months. Guilt By Association. Unwinnable tariff wars and weather challenges have dragged down Ag stocks this year. We believe CLXT is less exposed to these issues and can actually benefit from weak markets given its differentiated product offering in a commoditized space, yet the stock has underperformed its peers with more exposure to these variables. Lower Price Target, But Deep Value Opportunity. We believe the declines of 66% from its YTD high, and 32% in the past seven trading days alone are not justified and put the stock in deep value territory. Our lower price target is a reflection of adjustments to our model and assumed multiple, not a reflection of the value proposition which we believe remains significant." (8/8/2019) Has Calyxt been receiving favorable news coverage? News stories about CLXT stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Calyxt earned a media sentiment score of 0.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCalyxt. Are investors shorting Calyxt? Calyxt saw a decline in short interest in February. As of February 28th, there was short interest totaling 516,400 shares, a decline of 14.8% from the February 13th total of 606,300 shares. Based on an average daily trading volume, of 146,500 shares, the days-to-cover ratio is currently 3.5 days. Currently, 5.1% of the shares of the company are short sold. View Calyxt's Current Options Chain. Who are some of Calyxt's key competitors? Some companies that are related to Calyxt include American Vanguard (AVD), Marrone Bio Innovations (MBII), CVR Partners (UAN), Wynnstay Group (WYN), Evogene (EVGN), Eden Research (EDEN), Arcadia Biosciences (RKDA), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT). What other stocks do shareholders of Calyxt own? Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Cypress Semiconductor (CY), Molecular Templates (MTEM), Advanced Micro Devices (AMD), GW Pharmaceuticals PLC- (GWPH), Intel (INTC), Netflix (NFLX), Secureworks (SCWX), AbbVie (ABBV) and Eaton (ETN). Who are Calyxt's key executives? Calyxt's management team includes the following people: Mr. James A. Blome, Chief Exec. Officer (Age 56)Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)Mr. William F. Koschak, Chief Financial Officer (Age 50)Mr. Eric Dutang, Principal Accounting Officer (Age 45) When did Calyxt IPO? (CLXT) raised $101 million in an initial public offering (IPO) on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers. What is Calyxt's stock symbol? Calyxt trades on the NASDAQ under the ticker symbol "CLXT." How do I buy shares of Calyxt? Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Calyxt's stock price today? One share of CLXT stock can currently be purchased for approximately $2.90. How big of a company is Calyxt? Calyxt has a market capitalization of $95.67 million and generates $7.30 million in revenue each year. The company earns $-39,610,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. Calyxt employs 50 workers across the globe. View additional information about Calyxt. What is Calyxt's official website? The official website for Calyxt is http://www.calyxt.com/. How can I contact Calyxt? Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected] MarketBeat Community Rating for Calyxt (NASDAQ CLXT)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 241 (Thanks for Voting!)Underperform Votes: 243 (Thanks for Voting!)Total Votes: 484MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/1/2020 by MarketBeat.com StaffFeatured Article: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?
